Transformative Joint Venture Between Dixie Brands and Khiron Life Sciences Brings a Portfolio of Highly Recognized Cannabis-Infused Products to Latin America and Khiron's Kuida® Cosmeceutical Brand to the Federally legal U.S. CBD Cosmetic Market
Better Marijuana Stock Buy: Medical Marijuana Inc. vs. Insys Therapeutics
How Is Cannabis Stock Kushco Holdings Positioned in January?
Today's Research Reports on Trending Tickers: BioTime and Zynerba Pharmaceuticals
Biotechs You Need to Radar Now
Cannabis Growth Continues to Drive Technology Innovation for EnviroTechnologies International, Canopy Rivers, Aphria and WeedMD
Level Brands CEO Interview to Air on Bloomberg International on the RedChip Money Report
Isodiol International Inc. Announces Intent to Divest Kure Corp. as Part of Ongoing Efforts to Curb Shareholder Dilution
Research Report Identifies Cameco, American Equity Investment Life Holding, AG Mortgage Investment Trust, Arena Pharmaceuticals, Mimecast, and Aldeyra Therapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Corbus Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Emerald Health Therapeutics Announces Discharge of Litigation
Moving Average Crossover Alert: Marine Products
Edited Transcript of MPX earnings conference call or presentation 23-Jan-19 1:00pm GMT
Insys executive gave doctor lap dance while promoting drug, witness says
Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against 22nd Century Group, Inc. (XXII)
Pomerantz Law Firm Announces the Filing of a Class Action against 22nd Century Group, Inc. and Certain Officers – XXII
OrganiGram: Cannabis Industry Outlook
Medical Products Industry Outlook: Plenty of Upside Left
OrganiGram’s Margins Expand, Impact the Bottom Line
These 4 Healthcare Stocks Healthy With Potential Opportunities
Watch These 4 Marijuana Stocks On Tuesday (1/29/19)
Green Organic Dutchman’s Production Partner Gets Denmark License
4 Marijuana Stocks Stepping Up Their Game
/C O R R E C T I O N -- VirtualInvestorConferences.com/
Jim Cramer Shares His Predictions For The Cannabis Industry
OrganiGram Rose 18% after Its First-Quarter Earnings
These community banks are making more money than ever
Zynerba Pharmaceuticals News: Why ZYNE Stock Is Soaring Today
NBEV Stock Is a Plausible, If Risky, Path to CBD-Infused Gains
Watch These 4 Marijuana Stocks Set The Pace On Tuesday (1/29/19)
Before You Buy ReneSola Ltd (NYSE:SOL), Consider Its Volatility
Bio-Rad Laboratories, Inc. (NYSE:BIO): A Fundamentally Attractive Investment
Marijuana stocks rise after Organigram doubles revenue forecast